TY - JOUR T1 - What role will ‘gliptins’ play in glycemic control? JF - Cleveland Clinic Journal of Medicine JO - Cleve Clin J Med SP - 305 LP - 310 VL - 75 IS - 4 AU - Zachary Bloomgarden AU - Andrew Drexler Y1 - 2008/04/01 UR - http://www.ccjm.org/content/75/4/305.abstract N2 - The gliptins, a new class of oral drugs for type 2 diabetes mellitus, lower blood glucose levels by a novel mechanism: ie, by inhibiting the enzyme dipeptidyl peptidase 4, thereby increasing the circulating levels of incretins (gut hormones that can boost insulin levels). This article reviews the current evidence on the effectiveness of gliptins and suggests several ways in which these agents could be used in diabetes treatment. ER -